FDA Investigator: Vaishali J. Patel

- Vaishali J. Patel first started conducting FDA inspections in 2018, with the last inspection in 2024. Over that time, Vaishali J. Patel has conducted 42 inspections at 39 companies across 40 sites.

Documents

FDA 483 Eugia Pharma Specialities Limited, Riico Industrial Area | 2024

Out-of-stock
Vaishali J. Patel
Human Drugs Form 483

FDA 483 Lupin Ltd., Aurangabad | 2024

Out-of-stock
Vaishali J. Patel
Human Drugs Form 483

FDA 483 Sri Krishna Pharmaceuticals Limited - Unit IV, Sangareddy | 2023

Out-of-stock
Vaishali J. Patel
Animal Drugs & Feeds Form 483

FDA 483 Sri Krishna Pharmaceuticals, Ltd. - Unit III, Ranga Reddy District | 2023

Out-of-stock
Vaishali J. Patel
Human Drugs Form 483

FDA 483 Merck Serono SA (Vevey), Corsier-Sur-Vevey | 2023

Out-of-stock
Vaishali J. Patel
Human Drugs Form 483

FDA 483 Lonza AG, Visp | 2023

Out-of-stock
Vaishali J. Patel
Human Drugs Form 483

FDA 483 Nexus Pharmaceuticals Inc, Pleasant Prairie | 2023

Out-of-stock
Vaishali J. Patel
Human Drugs Form 483

FDA 483 I. Shay Cosmetics Inc, Carson | 2021

Out-of-stock
Vaishali J. Patel
Human Drug Form 483

FDA 483 Nexus Pharmaceuticals Inc, Lincolnshire | 2019

Out-of-stock
Vaishali J. Patel
Human Drug Form 483

FDA 483 Catalent Indiana, LLC, Bloomington | 2019

Out-of-stock
Vaishali J. Patel
Human Drug Form 483